Found: 23
Select item for more details and to access through your institution.
Molecular imaging in drug development.
- Published in:
- Nature Reviews Drug Discovery, 2008, v. 7, n. 7, p. 591, doi. 10.1038/nrd2290
- By:
- Publication type:
- Article
O1-02-07: In vivo characterization of 18F-BAY94-9172: A novel β-amyloid PET ligand for the diagnosis of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
IC-P3-208: In vivo characterization of 18F-BAY94-9172: A novel β-amyloid PET ligand for the diagnosis of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O1-04-02: Initial results from human studies of a novel F-18 PET ligand for brain beta-amyloid imaging
- Published in:
- 2007
- By:
- Publication type:
- Abstract
Preclinical evaluation of BAY 1075553, a novel <sup>18</sup>F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 1, p. 89, doi. 10.1007/s00259-013-2527-3
- By:
- Publication type:
- Article
<sup>124</sup>I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of <sup>131</sup>I-L19-SIP radioimmunotherapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1235, doi. 10.1007/s00259-009-1096-y
- By:
- Publication type:
- Article
Molecular targeting of angiogenesis for imaging and therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 9, p. 1327, doi. 10.1007/s00259-004-1648-0
- By:
- Publication type:
- Article
Evaluation of dosimetry, quantitative methods and test-retest variability of <sup>18</sup>F-PI-2620 PET for the assessment of tau deposits in the human brain.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236240
- By:
- Publication type:
- Article
Tau PET imaging with <sup>18</sup>F-PI-2620 in patients with Alzheimer’s disease and healthy controls: a first-in-human study.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236224
- By:
- Publication type:
- Article
<sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1094, doi. 10.2967/jnumed.116.188896
- By:
- Publication type:
- Article
Exploratory Clinical Investigation of (4S)-4-(3-<sup>18</sup>FFluoropropyl)-L-Glutamate PET of Inflammatory and Infectious Lesions.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 1, p. 67, doi. 10.2967/jnumed.115.164020
- By:
- Publication type:
- Article
(S)-4-(3-<sup>18</sup>F-Fluoropropyl)-L-Glutamic Acid: An <sup>18</sup>F-Labeled Tumor-Specific Probe for PET/CT Imaging--Dosimetry.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 6, p. 861, doi. 10.2967/jnumed.112.112581
- By:
- Publication type:
- Article
(4S)-4-(3-<sup>18</sup>F-Fluoropropyl)-L-Glutamate for Imaging of x<sub>C</sub> Transporter Activity in Hepatocellular Carcinoma Using PET: Preclinical and Exploratory Clinical Studies.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 1, p. 117, doi. 10.2967/jnumed.112.108704
- By:
- Publication type:
- Article
Targeting of HER2-Expressing Tumors with a Site-Specifically <sup>99m</sup>Tc-Labeled Recombinant Affibody Molecule, Z<sub>HER2:2395</sub>, with C-Terminally Engineered Cysteine.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 5, p. 781, doi. 10.2967/jnumed.108.056929
- By:
- Publication type:
- Article
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148628
- By:
- Publication type:
- Article
<sup>18</sup>F-Radiolabeling of Aromatic Compounds Using Triarylsulfonium Salts.
- Published in:
- European Journal of Organic Chemistry, 2012, v. 2012, n. 5, p. 889, doi. 10.1002/ejoc.201101730
- By:
- Publication type:
- Article
Reduction of Intimal Hyperplasia withRe-188-labeled Stents in a Rabbit Model at 7and 26 Weeks: An Experimental Study.
- Published in:
- CardioVascular & Interventional Radiology, 2005, v. 28, n. 5, p. 632, doi. 10.1007/s00270-004-0308-x
- By:
- Publication type:
- Article
Commentary to <sup>18</sup>F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi: Imaging Activated Platelets in Clots—Are We Getting There?
- Published in:
- Molecular Imaging, 2018, v. 17, p. 1, doi. 10.1177/1536012117749052
- By:
- Publication type:
- Article
Small-Animal PET of Tumor Angiogenesis Using a <sup>76</sup>Br-Labeled Human Recombinant Antibody Fragment to the ED-B Domain of Fibronectin.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 7, p. 1172, doi. 10.2967/jnumed.107.040477
- By:
- Publication type:
- Article
Imaging of Tumor Angiogenesis Using <sup>99</sup>mTc-Labeled Human Recombinant Anti-ED-B Fibronectin Antibody Fragments.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 10, p. 1707
- By:
- Publication type:
- Article
Radioimmunotherapy of Head and Neck Cancer Xenografts Using <sup>131</sup>I-Labeled Antibody L19-SIP for Selective Targeting of Tumor Vasculature.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 7, p. 1127
- By:
- Publication type:
- Article
Targeting of Endothelin Receptors for Molecular Imaging of Atherosclerosis in Rabbits.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 3, p. 400
- By:
- Publication type:
- Article
Molecular Imaging of Atherosclerosis Using a Technetium- 99m-Labeled Endothelin Derivative.
- Published in:
- Journal of Nuclear Medicine, 1998, v. 39, n. 10, p. 1819
- By:
- Publication type:
- Article